Colony Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $24M | Sell |
343,658
-13,137
| -4% | -$931K | 0.36% | 70 |
|
|
2023
Q2 | $24.7M | Sell |
356,795
-27,868
| -7% | -$1.98M | 0.35% | 72 |
|
|
2023
Q1 | $28.6M | Sell |
384,663
-34,977
| -8% | -$2.93M | 0.42% | 54 |
|
|
2022
Q4 | $39.1M | Buy |
419,640
+21,212
| +5% | +$2.05M | 0.55% | 42 |
|
|
2022
Q3 | $38M | Buy |
398,428
+7,242
| +2% | +$717K | 0.67% | 29 |
|
|
2022
Q2 | $36.2M | Buy |
391,186
+18,808
| +5% | +$1.84M | 0.62% | 33 |
|
|
2022
Q1 | $37.7M | Buy |
372,378
+64,905
| +21% | +$6.82M | 0.56% | 40 |
|
|
2021
Q4 | $31.7M | Sell |
307,473
-3,108
| -1% | -$287K | 0.56% | 42 |
|
|
2021
Q3 | $26.4M | Buy |
310,581
+11,872
| +4% | +$994K | 0.51% | 46 |
|
|
2021
Q2 | $24.9M | Buy |
298,709
+1,123
| +0.4% | +$92K | 0.5% | 52 |
|
|
2021
Q1 | $22.4M | Buy |
297,586
+93,362
| +46% | +$6.8M | 0.47% | 58 |
|
|
2020
Q4 | $13.9M | Sell |
204,224
-69,355
| -25% | -$4.51M | 0.32% | 78 |
|
|
2020
Q3 | $16M | Buy |
273,579
+42,614
| +18% | +$2.65M | 0.42% | 62 |
|
|
2020
Q2 | $15M | Buy |
230,965
+6,725
| +3% | +$423K | 0.43% | 61 |
|
|
2020
Q1 | $13.3M | Buy |
224,240
+11,481
| +5% | +$766K | 0.43% | 60 |
|
|
2019
Q4 | $15.8M | Buy |
212,759
+191,410
| +897% | +$13.4M | 0.4% | 70 |
|
|
2019
Q3 | $1.35M | Sell |
21,349
-3,084
| -13% | -$183K | 0.04% | 323 |
|
|
2019
Q2 | $1.33M | Buy |
24,433
+1,999
| +9% | +$108K | 0.04% | 334 |
|
|
2019
Q1 | $1.21M | Buy |
22,434
+6,406
| +40% | +$395K | 0.05% | 264 |
|
|
2018
Q4 | $1.05M | Buy |
16,028
+1,342
| +9% | +$100K | 0.05% | 252 |
|
|
2018
Q3 | $1.16M | Sell |
14,686
-2
| -0% | -$143 | 0.06% | 257 |
|
|
2018
Q2 | $945K | Sell |
14,688
-98
| -0.7% | -$6.46K | 0.05% | 267 |
|
|
2018
Q1 | $920K | Sell |
14,786
-156,493
| -91% | -$11.2M | 0.05% | 263 |
|
|
2017
Q4 | $12.4M | Sell |
171,279
-25,789
| -13% | -$1.87M | 0.78% | 40 |
|
|
2017
Q3 | $16M | Sell |
197,068
-3,571
| -2% | -$282K | 1.09% | 21 |
|
|
2017
Q2 | $16.1M | Buy |
200,639
+37,802
| +23% | +$2.98M | 1.15% | 19 |
|
|
2017
Q1 | $12.8M | Buy |
162,837
+7,891
| +5% | +$630K | 1.21% | 24 |
|
|
2016
Q4 | $12.2M | Sell |
154,946
-7,676
| -5% | -$621K | 1.31% | 17 |
|
|
2016
Q3 | $14.5M | Sell |
162,622
-3,531
| -2% | -$333K | 1.61% | 14 |
|
|
2016
Q2 | $15.9M | Sell |
166,153
-2,436
| -1% | -$243K | 1.75% | 10 |
|
|
2016
Q1 | $17.5M | Sell |
168,589
-5,289
| -3% | -$514K | 2.02% | 4 |
|
|
2015
Q4 | $17M | Buy |
173,878
+47
| +0% | +$4.6K | 1.55% | 6 |
|
|
2015
Q3 | $16.8M | Buy |
173,831
+469
| +0.3% | +$49.3K | 1.95% | 2 |
|
|
2015
Q2 | $18.2M | Buy |
173,362
+3,458
| +2% | +$353K | 1.92% | 2 |
|
|
2015
Q1 | $17.5M | Sell |
169,904
-50,848
| -23% | -$5.15M | 1.94% | 3 |
|
|
2014
Q4 | $21.3M | Sell |
220,752
-4,245
| -2% | -$374K | 2.22% | 1 |
|
|
2014
Q3 | $17.9M | Sell |
224,997
-1,126
| -0.5% | -$88.8K | 2.01% | 2 |
|
|
2014
Q2 | $17M | Sell |
226,123
-4,258
| -2% | -$322K | 2.27% | 2 |
|
|
2014
Q1 | $17.2M | Sell |
230,381
-11,838
| -5% | -$836K | 2.33% | 1 |
|
|
2013
Q4 | $17.3M | Buy |
242,219
+9,820
| +4% | +$631K | 2.42% | 1 |
|
|
2013
Q3 | $13.2M | Sell |
232,399
-9,260
| -4% | -$552K | 2.59% | 4 |
|
|
2013
Q2 | $13.8M | Buy |
+241,659
| New | +$14M | 2.76% | 4 |
|
Other funds holding CVS
Colony Group's CVS Position: Q3 2023 in Review
Colony Group reduced its CVS Health (CVS) stake by 3.7% in Q3 2023, selling an estimated $931K and leaving 343,658 shares worth $24M. The position accounts for 0.36% of the portfolio, ranked #70.
Colony Group first reported a position in CVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $39.1M in Q4 2022. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Colony Group held 343,658 shares of CVS Health worth $24M as of Q3 2023.
- Colony Group sold 13,137 CVS Health shares in Q3 2023, an estimated $931K.
- CVS Health made up 0.36% of Colony Group's portfolio in Q3 2023, its #70 holding.
- Colony Group first reported a position in CVS Health in Q2 2013 and has held it in 42 quarters since.
- Colony Group's CVS Health position peaked at $39.1M in Q4 2022.
- 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.